HPCAL1 and familial pancreatic carcinoma: Inhibition of HPCAL1 inhibited pancreatic cancer progression and pancreatitis development in a mouse model [104], suggesting that targeted enhancement of HPCAL1 expression may be a potential antitumor strategy.